AMOCLAN FORTE 625mg Price

Overview

Welcome to Dwaey, specifically on AMOCLAN FORTE 625mg Tablets page.
This medicine contains an important and useful components, as it consists of Co-amoxiclav.
AMOCLAN FORTE 625mg is available in the market in concentration 625mg (500mg + 125mg)/Tablet and in the form of Tablets.

AL HIKMA PHARMACEUTICALS is the producer of AMOCLAN FORTE 625mg and it is imported from JORDAN, The most popular alternatives of AMOCLAN FORTE 625mg are listed downward .

Mode Of Action

Clavulanic acid has a high affinity for and binds to certain ?-lactamases that generally inactivate amoxicillin by hydrolyzing its ?-lactam ring. Combining clavulanate potassium with amoxicillin extends the antibacterial spectrum of amoxicillin to include many bacteria normally resistant to amoxicillin and other penicillins and cephalosporins.

Indication

• Bacterial infections
• Acute otitis media
• Acute bacterial sinusitis
• Endocarditis
• Dental abscess
• Community-acquired pneumonia
• Acute uncomplicated UTI
• Uncomplicated gonorrhea
• Severe or recurrent resp tract infections

Precaution

History of allergy especially to cephalosporins, infectious mononucleosis, severe renal impairment. Lactation: Drug excreted in breast milk; use caution

Side Effects

• >10% Diarrhea (3-34%; varies upon dose and regimen) 1-10% Diaper rash (3.5%)
• Mycosis (3.3%)
• Nausea (2-3%)
• Rash (1-3%)
• Vomiting (1-2.2%)
• Loose stool (1.6%)
• Candidiasis (1.4%)
• Vaginitis (1%) <1% Hypersensitivity reactions
• Anaphylaxis
• Anemia
• Thrombocytopenia
• Leukopenia
• Agranulocytosis
• Hepatoxicity
• AST/ALT elevation
• Pseudomembranous colitis
• Serum sickness
• Abdominal discomfort
• Cholestatic jaundice
• Flatulence Potentially Fatal: Anaphylactic reaction with CV collapse esp with parenteral use.

Contra indication

Penicillin allergy.

Pregnancy and lactation

Pregnancy category: B

Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.